Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippa Easterbrook

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Virology|November 20, 2009
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1Avishek Nandi, Christine L Lavine, Pengcheng Wang, et al.
BMJ Open|May 3, 2022
Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-upBridget Louise Draper, Win Lei Yee, Sonjelle Shilton, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2019
Hepatitis B virus infection in children and adolescentsGiuseppe Indolfi, Philippa Easterbrook, Geoffrey Dusheiko, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2019
Hepatitis C virus infection in children and adolescentsGiuseppe Indolfi, Philippa Easterbrook, Geoffrey Dusheiko, et al.
Lancet (London, England)|December 11, 2007
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort studyAndrew N Phillips, Clifford Leen, Alan Wilson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2009
Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort studyLoveleen Bansi, Jo Turner, Richard Gilson, et al.
Journal of Clinical Epidemiology|March 30, 2010
Data linkage reduces loss to follow-up in an observational HIV cohort studyTeresa Hill, Loveleen Bansi, Caroline Sabin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 24, 2021
Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, IndiaJessica Markby, Ekta Gupta, Divya Soni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2024
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysisSeth Inzaule, Philippa Easterbrook, Ashley Latona, et al.
AIDS (London, England)|January 9, 2010
Late diagnosis in the HAART era: proposed common definitions and associations with mortality, Caroline A Sabin, Achim Schwenk, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Virology|November 20, 2009
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1Avishek Nandi, Christine L Lavine, Pengcheng Wang, et al.
BMJ Open|May 3, 2022
Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-upBridget Louise Draper, Win Lei Yee, Sonjelle Shilton, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2019
Hepatitis B virus infection in children and adolescentsGiuseppe Indolfi, Philippa Easterbrook, Geoffrey Dusheiko, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2019
Hepatitis C virus infection in children and adolescentsGiuseppe Indolfi, Philippa Easterbrook, Geoffrey Dusheiko, et al.
Lancet (London, England)|December 11, 2007
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort studyAndrew N Phillips, Clifford Leen, Alan Wilson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2009
Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort studyLoveleen Bansi, Jo Turner, Richard Gilson, et al.
Journal of Clinical Epidemiology|March 30, 2010
Data linkage reduces loss to follow-up in an observational HIV cohort studyTeresa Hill, Loveleen Bansi, Caroline Sabin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 24, 2021
Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, IndiaJessica Markby, Ekta Gupta, Divya Soni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2024
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysisSeth Inzaule, Philippa Easterbrook, Ashley Latona, et al.
AIDS (London, England)|January 9, 2010
Late diagnosis in the HAART era: proposed common definitions and associations with mortality, Caroline A Sabin, Achim Schwenk, et al.
Pageof 15